Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
PI3K/MTOR INHIBITOR LY3023414
Central Nervous System Neoplasm
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Rhabdoid Tumor
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Soft Tissue Sarcoma
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P2B (57)
PI3K/MTOR INHIBITOR LY3023414
Wilms Tumor
National Cancer Institute (NCI)P2B (57)
Selumetinib
Central Nervous System Neoplasm
National Cancer Institute (NCI)P2B (57)
Selumetinib
Neuroblastoma
National Cancer Institute (NCI)P2B (57)
Selumetinib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Langerhans Cell Histiocytosis
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Malignant Glioma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Rhabdomyosarcoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Ependymoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Ewing Sarcoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Glioma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Hepatoblastoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Malignant Germ Cell Tumor
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Medulloblastoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Neuroblastoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Osteosarcoma
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Central Nervous System Neoplasm
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P2B (57)
Tazemetostat
Wilms Tumor
National Cancer Institute (NCI)P2B (57)
Tiragolumab
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P2B (57)
Atezolizumab
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2/3B (57)
Showing 851 to 875 of 3,272 assets
PreviousPage 35 of 131Next